News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Shannon Matheny

Articles by Shannon Matheny

29 ELEVATE: A Phase 1b/2, Open-Label, Umbrella Study Evaluating Elacestrant in Various Combinations in Patients (pts) With Estrogen Receptor–Positive (ER+), HER2-Negative (HER2–) Locally Advanced or Metastatic Breast Cancer (mBC)

29 ELEVATE: A Phase 1b/2, Open-Label, Umbrella Study Evaluating Elacestrant in Various Combinations in Patients (pts) With Estrogen Receptor–Positive (ER+), HER2-Negative (HER2–) Locally Advanced or Metastatic Breast Cancer (mBC)

ByHope S. Rugo, MD,Aditya Bardia, MD, MPH, FASCO,Erika P. Hamilton, MD,Sara A. Hurvitz, MD,Sara M. Tolaney, MD, MPH,Virginia Kaklamani, MD, DSc,Paula Muñoz Romero,Shannon Matheny,Kathy Puyana Theall,Joyce A. O’Shaughnessy

July 21st 2024

Latest Updated Articles

Trending on CancerNetwork

How Supportive Care Methods Can Improve Oncology Outcomes

AQUILA Shows “Striking” Benefits With Daratumumab in Smoldering Myeloma

Chlorotoxin-Based Therapy Shows Safety, Feasibility in Glioblastoma

Pembrolizumab Regimen May Show Synergy in Melanoma Populations

FDA Clears Phase 3 Lacutamab Protocol in Cutaneous T-Cell Lymphomas

© 2025 MJH Life Sciences^®

All rights reserved.